Systematic comparisons between Lyme disease and post-treatment Lyme disease syndrome in the U.S. with administrative claims data

Piesman, 2004, Lyme borreliosis in Europe and North America, Parasitology, 129, S191, 10.1017/S0031182003004694 Pitrak, 2022, Diagnosis of Lyme disease, JAMA, 327, 676, 10.1001/jama.2022.0081 Sanchez, 2016, Diagnosis, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: a review, JAMA, 315, 1767, 10.1001/jama.2016.2884 Steere, 2016, Lyme borreliosis, Nat Rev Dis Primer, 2, 1, 10.1038/nrdp.2016.90 Wormser, 2006, The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America, Clin Infect Dis, 43, 1089, 10.1086/508667 Lantos, 2020, Clinical practice guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 guidelines for the prevention, diagnosis and treatment of Lyme disease, Clin Infect Dis, 72, 1, 10.1093/cid/ciaa1215 Melia, 2016, Time for a different approach to Lyme disease and long-term symptoms, N Engl J Med, 374, 1277, 10.1056/NEJMe1502350 Rebman, 2017, The clinical, symptom, and quality-of-life characterization of a well-defined group of patients with posttreatment Lyme disease syndrome, Front Med, 4, 224, 10.3389/fmed.2017.00224 Kugeler, 2021, Estimating the frequency of Lyme disease diagnoses, United States, 2010–2018, Emerg Infect Dis, 27, 616, 10.3201/eid2702.202731 Schwartz, 2021, Use of commercial claims data for evaluating trends in Lyme disease diagnoses, United States, 2010-2018, Emerg Infect Dis, 27, 499, 10.3201/eid2702.202728 Casey, 2016, Using electronic health records for population health research: a review of methods and applications, Annu Rev Public Health, 37, 61, 10.1146/annurev-publhealth-032315-021353 Adrion, 2015, Health care costs, utilization and patterns of care following Lyme disease, PLoS One, 10, 10.1371/journal.pone.0116767 Klimek, 2015, Quantification of diabetes comorbidity risks across life using nation-wide big claims data, PLoS Comput Biol, 11, 10.1371/journal.pcbi.1004125 Unger, 2018, Using medicare claims to examine long-term prostate cancer risk of finasteride in the prostate cancer prevention trial, JNCI J Natl Cancer Inst, 110, 1208 Rogers, 2015, Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the US population, 2012, JAMA Dermatol, 151, 1081, 10.1001/jamadermatol.2015.1187 Bearelly, 2008, Identification of patients with diabetic macular edema from claims data: a validation study, Arch Ophthalmol, 126, 986, 10.1001/archopht.126.7.986 Rhee, 2017, Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009-2014, JAMA, 318, 1241, 10.1001/jama.2017.13836 Eisenberg, 2015, Increased risk of cancer in infertile men: analysis of U.S. claims data, J Urol, 193, 1596 Psaty Bruce, 2016, Study of cardiovascular health outcomes in the era of claims data, Circulation, 133, 156, 10.1161/CIRCULATIONAHA.115.018610 Hebert, 1999, Identifying persons with diabetes using medicare claims data, Am J Med Qual, 14, 270, 10.1177/106286069901400607 Tseng, 2015, Using nation-wide health insurance claims data to augment Lyme disease surveillance, Vector Borne Zoonotic Dis, 15, 591, 10.1089/vbz.2015.1790 Nelson, 2015, Incidence of clinician-diagnosed Lyme disease, United States, 2005–2010, Emerg Infect Dis, 21, 1625, 10.3201/eid2109.150417 Aucott, 2013, Development of a foundation for a case definition of post-treatment Lyme disease syndrome, Int J Infect Dis, 17, e443, 10.1016/j.ijid.2013.01.008 Denny, 2010, PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene–disease associations, Bioinformatics, 26, 1205, 10.1093/bioinformatics/btq126 Tennekes, 2018, Tmap: thematic maps in R, J Stat Softw, 84, 1 White, 2018, Lyme disease surveillance in New York state: an assessment of case underreporting, Zoonoses Public Health, 65, 238, 10.1111/zph.12307 Marques, 2008, Chronic Lyme disease: a review, Infect Dis Clin North Am, 22, 341, 10.1016/j.idc.2007.12.011 Weitzner, 2015, Long-term assessment of post-treatment symptoms in patients with culture-confirmed early Lyme disease, Clin Infect Dis, 61, 1800, 10.1093/cid/civ735 Ichikawa, 2019, Lyme disease patient trajectories learned from electronic medical data for stratification of disease risk and therapeutic response, Sci Rep, 9, 4460, 10.1038/s41598-019-41128-x Fitzgerald, 2021, Metabolic response in patients with post-treatment Lyme disease symptoms/syndrome, Clin Infect Dis, 73, e2342, 10.1093/cid/ciaa1455 Shapiro, 2014, Lyme disease, N Engl J Med, 370, 1724, 10.1056/NEJMcp1314325 Patel, 2000, Death from inappropriate therapy for Lyme disease, Clin Infect Dis, 31, 1107, 10.1086/318138 Feder, 2007, A critical appraisal of “chronic Lyme disease”, N Engl J Med, 357, 1422, 10.1056/NEJMra072023 Rutz, 2018, Exploring an alternative approach to Lyme disease surveillance in Maryland, Zoonoses Public Health, 65, 254, 10.1111/zph.12446